Vitality Watch

Dossier pubmed review 06-oct-2026
Narrative review or expert overview without new data

Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.

Key claim: A multimodal, cross-scale technology framework can causally trace how the mitochondria–pyroptosis axis—via oxidative mtDNA, NLRP3 activation, and tissue pyroptotic hotspots—links to muscle-mass loss and cognitive decline in aging.

Abstract

Population aging drives a parallel increase in muscle atrophy and cognitive decline, two major causes of disability in older adults. Mitochondrial dysfunction and chronic inflammation are core drivers of aging, with pyroptosis serving as a critical link between them. However, conventional single‑technique approaches capture only fragmented, static information and fail to bridge molecular events with whole‑organism phenotypes. This review introduces a unique integrative perspective that weaves established multimodal technologies ranging from molecular interaction analysis and absolute quantification to cellular metabolic and electrophysiological recordings, tissue clearing and laser microdissection, and finally to in vivo imaging and body composition analysis into a coherent, cross‑scale chain of evidence. By applying this paradigm to the mitochondria‑pyroptosis axis, we reveal how oxidative mitochondrial DNA enhances NLRP3 binding, how aged cells exhibit metabolic vulnerability and electrophysiological susceptibility, how pyroptotic hotspots form with spatial heterogeneity in tissues, and how pyroptosis signals quantitatively correlate with the decline in muscle mass and cognitive function. The core contribution of this review is the methodological framework of multimodal integration that enables causal tracing from molecular triggers to functional outcomes. This paradigm offers a transferable strategy for dissecting complex aging mechanisms and provides a theoretical foundation for targeting the mitochondria‑pyroptosis axis in precision anti‑aging interventions.

Why this matters

This paper is a methodological-integration bet rather than a new biological result: it argues that cross-scale multimodal technologies (single-cell/spatial omics, advanced imaging, AI) can resolve a single mitochondria→mtDNA→NLRP3→pyroptosis axis as the shared causal chain behind two outwardly distinct aging phenotypes, sarcopenia and cognitive decline. For a mechanism area already tracking mtDNA-driven cGAS–STING and NLRP3 threads piecemeal, the contribution is a unifying framing and a methods roadmap, not new primary data. Its weight depends on whether the predicted tissue-specific pyroptotic hotspots are actually mapped and perturbed in follow-up work.

Source

Link

Briefing card

Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.
Stage: review · pubmed · 06-oct-2026

A multimodal, cross-scale technology framework can causally trace how the mitochondria–pyroptosis axis—via oxidative mtDNA, NLRP3 activation, and tissue pyroptotic hotspots—links to muscle-mass loss and cognitive decline in aging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.ymeth.2026.10.001

build build 880 · 2bcef25 · 2026-11-18